Luther King Capital Management (LKCM)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$118M Buy
983,617
+510
+0.1% +$58.9K 0.51% 51
2025
Q4
$103M Sell
983,107
-19,710
-2% -$1.85M 0.42% 60
2025
Q3
$84.2M Sell
1,002,817
-263,609
-21% -$21.7M 0.35% 67
2025
Q2
$100M Sell
1,266,426
-101,611
-7% -$8.08M 0.44% 60
2025
Q1
$123M Sell
1,368,037
-349,697
-20% -$32.6M 0.57% 51
2024
Q4
$171M Buy
1,717,734
+28,830
+2% +$2.97M 0.74% 41
2024
Q3
$192M Buy
1,688,904
+44,795
+3% +$5.32M 0.82% 36
2024
Q2
$204M Sell
1,644,109
-4,786
-0.3% -$616K 0.92% 32
2024
Q1
$218M Sell
1,648,895
-5,362
-0.3% -$661K 0.98% 29
2023
Q4
$180M Sell
1,654,257
-53,763
-3% -$5.58M 0.87% 33
2023
Q3
$176M Buy
1,708,020
+39,354
+2% +$4.24M 0.91% 33
2023
Q2
$193M Buy
1,668,666
+16,390
+1% +$1.86M 0.96% 33
2023
Q1
$176M Buy
1,652,276
+25,429
+2% +$2.75M 0.93% 33
2022
Q4
$180M Buy
1,626,847
+65,074
+4% +$6.65M 0.99% 33
2022
Q3
$135M Buy
1,561,773
+20,115
+1% +$1.8M 0.8% 38
2022
Q2
$141M Buy
1,541,658
+20,630
+1% +$1.83M 0.79% 41
2022
Q1
$125M Buy
1,521,028
+29,850
+2% +$2.35M 0.61% 51
2021
Q4
$114M Sell
1,491,178
-46,421
-3% -$3.7M 0.52% 61
2021
Q3
$115M Sell
1,537,599
-78,807
-5% -$5.99M 0.57% 55
2021
Q2
$126M Sell
1,616,406
-334,167
-17% -$24.9M 0.61% 53
2021
Q1
$143M Sell
1,950,573
-82,289
-4% -$6.07M 0.77% 41
2020
Q4
$159M Sell
2,032,862
-4,998
-0.2% -$382K 0.89% 35
2020
Q3
$161M Buy
2,037,860
+5,632
+0.3% +$441K 1.02% 32
2020
Q2
$150M Buy
2,032,228
+24,870
+1% +$1.87M 1.04% 30
2020
Q1
$147M Buy
2,007,358
+7,571
+0.4% +$595K 1.28% 25
2019
Q4
$174M Buy
1,999,787
+27,853
+1% +$2.29M 1.16% 32
2019
Q3
$158M Buy
1,971,934
+46,212
+2% +$3.7M 1.15% 33
2019
Q2
$154M Buy
1,925,722
+72,980
+4% +$5.59M 1.12% 32
2019
Q1
$147M Buy
1,852,742
+50,355
+3% +$3.77M 1.12% 32
2018
Q4
$131M Buy
1,802,387
+23,470
+1% +$1.66M 1.17% 31
2018
Q3
$120M Buy
1,778,917
+59,911
+3% +$3.82M 0.91% 39
2018
Q2
$99.6M Buy
1,719,006
+78,937
+5% +$4.45M 0.81% 45
2018
Q1
$85.2M Buy
1,640,069
+53,911
+3% +$2.91M 0.71% 52
2017
Q4
$85.2M Sell
1,586,158
-170,092
-10% -$9.43M 0.7% 51
2017
Q3
$107M Buy
1,756,250
+47,706
+3% +$2.89M 0.94% 41
2017
Q2
$104M Buy
1,708,544
+94,444
+6% +$5.75M 0.94% 42
2017
Q1
$97.9M Buy
1,614,100
+80,304
+5% +$4.87M 0.9% 44
2016
Q4
$86.2M Buy
1,533,796
+38,503
+3% +$2.25M 0.82% 46
2016
Q3
$89M Sell
1,495,293
-27,689
-2% -$1.62M 0.87% 47
2016
Q2
$83.7M Sell
1,522,982
-10,090
-0.7% -$537K 0.82% 49
2016
Q1
$77.4M Sell
1,533,072
-132,728
-8% -$6.5M 0.77% 50
2015
Q4
$84M Sell
1,665,800
-149,053
-8% -$7.51M 0.79% 47
2015
Q3
$85.5M Sell
1,814,853
-40,562
-2% -$2.15M 0.83% 40
2015
Q2
$101M Sell
1,855,415
-98,645
-5% -$5.53M 0.87% 39
2015
Q1
$107M Buy
1,954,060
+34,998
+2% +$1.98M 0.9% 41
2014
Q4
$104M Buy
1,919,062
+56,756
+3% +$3.16M 0.84% 39
2014
Q3
$105M Buy
1,862,306
+88,180
+5% +$4.95M 0.86% 38
2014
Q2
$97.9M Buy
1,774,126
+142,845
+9% +$7.79M 0.77% 42
2014
Q1
$88.4M Buy
1,631,281
+111,772
+7% +$5.79M 0.72% 45
2013
Q4
$72.6M Sell
1,519,509
-17,971
-1% -$821K 0.59% 47
2013
Q3
$69.8M Buy
1,537,480
+461,339
+43% +$21.1M 0.6% 46
2013
Q2
$47.7M Buy
+1,076,141
New +$48.1M 0.44% 69

Other funds holding MRK

Luther King Capital Management (LKCM)'s MRK Position: Q1 2026 in Review

Luther King Capital Management (LKCM) increased its Merck (MRK) stake by 0.05% in Q1 2026, buying an estimated $58.9K and bringing the position to 983,617 shares worth $118M. The position accounts for 0.51% of the portfolio, ranked #51.

Luther King Capital Management (LKCM) first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $218M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Luther King Capital Management (LKCM) held 983,617 shares of Merck worth $118M as of Q1 2026.
  • Luther King Capital Management (LKCM) bought 510 Merck shares in Q1 2026, an estimated $58.9K.
  • Merck made up 0.51% of Luther King Capital Management (LKCM)'s portfolio in Q1 2026, its #51 holding.
  • Luther King Capital Management (LKCM) first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Luther King Capital Management (LKCM)'s Merck position peaked at $218M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2026, filed 11 May 2026.